Influenza virus vaccine 2023-2024 (quadrivalent - Darwin/Georgia/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 mL Prefilled Syringe
RxNorm 2641885

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2641885 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: influenza virus vaccine 2023-2024 (quadrivalent - Darwin/Georgia/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 mL Prefilled Syringe.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
0.5 mL influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Georgia/12/2022 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 mg/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 mg/ML Prefilled Syringe
Primary clinical definition
AUI:12820604
PSN
Influenza virus vaccine 2023-2024 (quadrivalent - Darwin/Georgia/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 mL Prefilled Syringe
AUI:12820612
SY
Influenza virus vaccine 2023-2024 (quadrivalent - Darwin/Georgia/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 mL Prefilled Syringe
AUI:12820611

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCD

Semantic Clinical Drug (SCD):
0.5 mL influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Georgia/12/2022 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 mg/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 mg/ML Prefilled Syringe
(Atom ID: 12820604)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
0.5 ML influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Georgia/12/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2641885
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12820604
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
2641885
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{2056526} 2056525
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{2605726} 2605723
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{2605728} 2605725
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{2641878} 2641877
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{2056526} 2056525
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{2605726} 2605723
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{2605728} 2605725
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{2641878} 2641877
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2056526} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2605726} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2605728} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2641878} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN QUANTITY
0.5 ML
Normal Form quantity factor
RXTERM FORM
Prefilled Syringe
The RxTerm dose form name for this drug

PSN

Prescribable Name (PSN):
Influenza virus vaccine 2023-2024 (quadrivalent - Darwin/Georgia/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 mL Prefilled Syringe
(Atom ID: 12820612)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
influenza virus vaccine 2023-2024 (quadrivalent - Darwin/Georgia/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 ML Prefilled Syringe
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2641885
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12820612
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2641885
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

SY

Synonym (SY):
Influenza virus vaccine 2023-2024 (quadrivalent - Darwin/Georgia/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 mL Prefilled Syringe
(Atom ID: 12820611)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
influenza virus vaccine 2023-2024 (quadrivalent - Darwin/Georgia/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 ML Prefilled Syringe
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2641885
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12820611
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2641885
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Influenza Vaccine, Inactivated or Recombinant


Why get vaccinated? Influenza vaccine can prevent influenza (flu). Flu is a contagious disease that spreads around the United States every year, usually between October and May. Anyone can get the flu, but it is more dangerous for some people. Infants and young children, people 65 years of age and older, pregnant people, and people with certain health conditions or a weakened immune system are at greatest risk of flu complications. Pneumonia, bronchitis, sinus infections and ear infections are examples of flu-related complications. If you have a medical condition, such as heart disease, cancer or diabetes, flu can make it worse. Flu can cause fever and chills, sore throat, muscle aches, fatigue, cough, headache, and runny or stuffy nose. Some people may have vomiting and diarrhea, though this is more common in children than adults. Each year thousands of people in the United States die from flu, and many more are hospitalized. Flu vaccine prevents millions of illnesses and flu-related visits to the doctor each year.
[Learn More]


* Please review the disclaimer below.